Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
HUTCHMED (China) Limited (HKG:0013)
Hong Kong
· Delayed Price · Currency is HKD
Watchlist
Compare
25.70
+0.50 (1.98%)
Aug 15, 2025, 4:08 PM HKT
Overview
Financials
Statistics
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Full Width
Year Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
NaN - NaN
Oncology/Immunology - Marketed Products
2.12B
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Marketed Products Growth
64.85%
Log In
Log In
Log In
Log In
Upgrade
Other Ventures
2.08B
Log In
Log In
Log In
Log In
Upgrade
Other Ventures Growth
-14.04%
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Research and Development
716.55M
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Research and Development Growth
-74.89%
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Full Width
Year Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
NaN - NaN
China
3.53B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-7.01%
Log In
Log In
Log In
Log In
Upgrade
United States and Others
1.39B
Log In
Log In
Log In
Log In
Upgrade
United States and Others Growth
-49.82%
Log In
Log In
Log In
Log In
Upgrade